Eledon Pharmaceuticals
ELDN
ELDN
28 hedge funds and large institutions have $14.3M invested in Eledon Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
28
Holding in Top 10
–
Calls
$6K
Puts
–
Top Buyers
| 1 | +$825K | |
| 2 | +$6.79K | |
| 3 | +$5.48K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.65K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$716 |
Top Sellers
| 1 | -$1.03M | |
| 2 | -$37.8K | |
| 3 | -$23.2K | |
| 4 |
Two Sigma Investments
New York
|
-$18.5K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12.8K |